Viewpoint: Medical MJ Resked: Implications for Insurance Coverage, Capacity and Compliance

The Department of Justice issued an order on April 23, rescheduling state-licensed medical marijuana and Food & Drug Administration-approved cannabis products to Schedule III of the Controlled Substances Act (CSA). The order is also expected to jumpstart the stalled Drug …

Leave a Comment

Your email address will not be published. Required fields are marked *